Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 Immunotherapy

IMPORTANCE: Anti–programmed cell death 1 (anti–PD-1) immunotherapy features a durable response and improved survival in a small subset of patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). The association between plasma Epstein-Barr virus (EBV) DNA titer dynamics and efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian-Ying, Wei, Xiao-Li, Ren, Chao, Zhang, Yang, Hu, Yao-Fang, Li, Jia-Yu, Chen, Jun-Liang, Wang, Yi-Qin, Han, Fei, Wang, Feng-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889459/
https://www.ncbi.nlm.nih.gov/pubmed/35230439
http://dx.doi.org/10.1001/jamanetworkopen.2022.0587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889459/
https://www.ncbi.nlm.nih.gov/pubmed/35230439
http://dx.doi.org/10.1001/jamanetworkopen.2022.0587

Ejemplares similares